Dermata Therapeutics, Inc. (DRMA): Nasdaq/NYSE listing notice — Dermata Therapeutics receives Nasdaq delisting notice for bid price non-compliance

Dermata Therapeutics, Inc.

Nasdaq notice dated Nov 15, 2023 for failing $1.00 minimum bid price for 30 consecutive business days.
Company has 180 calendar days, until May 13, 2024, to regain compliance by closing at $1.00+ for 10 consecutive days.
If not cured, may qualify for additional 180-day period with reverse stock split and other conditions.
Company is evaluating options to regain compliance; business operations unaffected.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Dermata Therapeutics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

November 15, 2023, Dermata Therapeutics, Inc. (the “ Company ”) received a written notice (the “ Notice ”) from the Listing Qualifications Department of The Nasdaq Stock Market (“ Nasdaq ”) indicating that the Company is not in compliance with the $1.00 Minimum Bid Price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market (the “ Bid Price Requirement ”). The Notice does not result in the immediate delisting of the Company’s common stock from The Nasdaq Capital Market. The Nasdaq Listing Rules require listed securities to maintain a minimum

View on SEC.gov

Browse all listing & compliance notices →

Dermata Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001654954-23-014446

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.